April 2024 – Page 4 – Get News Story

Psoriatic Arthritis Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight

DelveInsight’s ‘Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of psoriatic arthritis in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Key Takeaways from Psoriatic Arthritis Market Research Report

The increase in Psoriatic Arthritis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
As per DelveInsight analysis, the Psoriatic Arthritis Market is anticipated to witness growth at a considerable CAGR.
The leading Psoriatic Arthritis Companies working in the market include AbbVie, Amgen, Johnson & Johnson, Bristol, Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly and Company, and UCB Biosciences Inc., and others.
Promising Psoriatic Arthritis Therapies in the various stages of development include NDI-034858, Alefacept, Methotrexate, Etanercept, UCB4940 40 mg, and others.
April 2024:- Novartis Pharmaceuticals- A 28-week, Randomized, Double-blind, Active Controlled, Multicenter Study to Evaluate the Efficacy of Subcutaneously Administered Secukinumab Compared to Ustekinumab in Adult Patients With Psoriatic Arthritis and Failure of TNFα- Inhibitor Treatment (AgAIN).
April 2024:- UCB Biopharma SRL- A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis. This is a study to assess the long-term safety, long-term efficacy and tolerability of bimekizumab administered subcutaneously (sc) in adult subjects with psoriatic arthritis (PsA).

Discover which therapies are expected to grab the Psoriatic Arthritis Market Share @ Psoriatic Arthritis Market Outlook

Psoriatic Arthritis Overview

Psoriatic arthritis is a type of arthritis that affects some people who have psoriasis, a chronic skin condition characterized by red, scaly patches. Psoriatic arthritis can cause inflammation in the joints, leading to pain, stiffness, and swelling. It typically affects the joints of the fingers, toes, wrists, knees, and ankles, but can also affect other joints and even the spine.

Psoriatic Arthritis Epidemiology Insights

The epidemiology section of Psoriatic Arthritis offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

Download the report to understand which factors are driving Psoriatic Arthritis Epidemiology trends @ Psoriatic Arthritis Epidemiological Insights

Psoriatic Arthritis Drugs Market

The Psoriatic Arthritis Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Psoriatic Arthritis signaling in Psoriatic Arthritis are likely to uncover new therapeutic targets and further expand treatment options for patients.

Psoriatic Arthritis Treatment Market Landscape

The Psoriatic Arthritis treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Psoriatic Arthritis has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To learn more about Psoriatic Arthritis treatment guidelines, visit @ Psoriatic Arthritis Treatment Market Landscape

Psoriatic Arthritis Market Outlook

The report’s outlook on the Psoriatic Arthritis market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Psoriatic Arthritis therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Psoriatic Arthritis drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Psoriatic Arthritis market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.

Psoriatic Arthritis Drugs Uptake

The drug chapter of the Psoriatic Arthritis report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Psoriatic Arthritis.

Major Psoriatic Arthritis Companies

Several Psoriatic Arthritis Companies working in the market include AbbVie, Amgen, Johnson & Johnson, Bristol, Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly and Company, UCB Biosciences Inc., and others.

Learn more about the FDA-approved drugs for Psoriatic Arthritis @ Drugs for Psoriatic Arthritis Treatment

Scope of the Psoriatic Arthritis Market Report

Coverage- 7MM
Psoriatic Arthritis Companies- AbbVie, Amgen, Johnson & Johnson, Bristol, Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly and Company, and UCB Biosciences Inc., and others.
Psoriatic Arthritis Therapies- NDI-034858, Alefacept, Methotrexate, Etanercept, UCB4940 40 mg, and others.
Psoriatic Arthritis Market Dynamics: Psoriatic Arthritis Market Drivers and Barriers
Psoriatic Arthritis Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about Psoriatic Arthritis Drugs in development @ Psoriatic Arthritis Clinical Trials Assessment

Table of Content

1. Key Insights

2. Report Introduction

3. Psoriatic Arthritis Market Overview at a Glance

4. Executive Summary of Psoriatic Arthritis

5. Disease Background and Overview

6. Epidemiology and Patient Population

7. Patient Journey of Psoriatic Arthritis

8. Marketed Products

9. Emerging Therapies

10. Other Assets

11. Psoriatic Arthritis (PsA): Seven Major Market Analysis

12. SWOT Analysis

13. KOL Views

14. Unmet Needs

15. Market Access

16. Acronyms and Abbreviations

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Psoriatic Arthritis Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight

IgA Nephropathy Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight

DelveInsight’s “IgA Nephropathy Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the IgA Nephropathy (IgAN), historical and forecasted epidemiology as well as the IgA Nephropathy (IgAN) market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Key Takeaways from the IgA Nephropathy Market Research Report

The increase in IgA Nephropathy Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
As per DelveInsight analysis, the IgA Nephropathy Market is anticipated to witness growth at a considerable CAGR.
The leading IgA Nephropathy Companies working in the market include Calliditas Therapeutics AB, Travere Therapeutics Inc., Omeros, Novartis Pharmaceuticals, Chinook Therapeutics, Vera Therapeutics, and others.
Promising IgA Nephropathy Therapies in the various stages of development include Omega-3 fatty acid ethylester90, Budesonide, Tacrolimus, LNP023, and others.
April 2024: Chinook Therapeutics- A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy. Parts 1 and 2 will be performed in a double-blind manner, for clinical research personnel interacting with study participants. An unblinded pharmacist will prepare the doses of investigational study drugs.
April 2024:- Novartis Pharmaceuticals- A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan in Adult Participants With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301.

Discover which therapies are expected to grab the IgA Nephropathy Market Share @ IgA Nephropathy Market Outlook

IgA Nephropathy Overview

IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when an antibody called immunoglobulin A (IgA) builds up in the kidneys. Normally, IgA helps the body fight infections, but in IgA nephropathy, it accumulates in the kidneys, leading to inflammation and damage over time. This can result in symptoms like blood in the urine, proteinuria (protein in the urine), high blood pressure, and swelling in the legs and feet. Over time, it can progress to chronic kidney disease and, in some cases, kidney failure.

IgA Nephropathy Epidemiology Insights

The epidemiology section of IgA Nephropathy offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

Download the report to understand which factors are driving IgA Nephropathy Epidemiology trends @ IgA Nephropathy Epidemiological Insights

IgA Nephropathy Drugs Market

The IgA Nephropathy Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying IgA Nephropathy signaling in IgA Nephropathy are likely to uncover new therapeutic targets and further expand treatment options for patients.

IgA Nephropathy Treatment Market Landscape

The IgA Nephropathy treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of IgA Nephropathy has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To learn more about IgA Nephropathy treatment guidelines, visit @ IgA Nephropathy Treatment Market Landscape

IgA Nephropathy Market Outlook

The report’s outlook on the IgA Nephropathy market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing IgA Nephropathy therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed IgA Nephropathy drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed IgA Nephropathy market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.

IgA Nephropathy Drugs Uptake

The drug chapter of the IgA Nephropathy report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to IgA Nephropathy.

Major IgA Nephropathy Companies

Several IgA Nephropathy Companies working in the market include Calliditas Therapeutics AB, Travere Therapeutics Inc., Omeros, Novartis Pharmaceuticals, Chinook Therapeutics, Vera Therapeutics, and others.

Learn more about the FDA-approved drugs for IgA Nephropathy @ Drugs for IgA Nephropathy Treatment

Scope of the IgA Nephropathy Market Report

Coverage- 7MM
IgA Nephropathy Companies- Calliditas Therapeutics AB, Travere Therapeutics Inc., Omeros, Novartis Pharmaceuticals, Chinook Therapeutics, Vera Therapeutics, and others.
IgA Nephropathy Therapies- Omega-3 fatty acid ethylester90, Budesonide, Tacrolimus, LNP023, and others.
IgA Nephropathy Market Dynamics: IgA Nephropathy Market Drivers and Barriers
IgA Nephropathy Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about IgA Nephropathy Drugs in development @ IgA Nephropathy Clinical Trials Assessment

Table of Content

1. Key Insights

2. Executive Summary of IgA Nephropathy (IgAN)

3. Competitive Intelligence Analysis for IgA Nephropathy (IgAN)

4. IgA Nephropathy (IgAN): Market Overview at a Glance

5. IgA Nephropathy (IgAN): Disease Background and Overview

6. Patient Journey

7. IgA Nephropathy (IgAN) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. IgA Nephropathy (IgAN) Unmet Needs

10. Key Endpoints of IgA Nephropathy (IgAN) Treatment

11. IgA Nephropathy (IgAN) Marketed Products

12. IgA Nephropathy (IgAN) Emerging Therapies

13. IgA Nephropathy (IgAN): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of IgA Nephropathy (IgAN)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

About Us

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: IgA Nephropathy Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight

Sweeteners Market Size, Share, Industry Overview, Trends, Growth Drivers, Business Opportunities, and Leading Players

“MarketsandMarkets™”

Sweeteners Market by Product (Sucrose, High-fructose Corn Syrup, Natural Sweeteners, Artificial Sweeteners, Novel Sweeteners, and Polyols), Sales Channel (Direct and Indirect), Type, Form, Application and Region – Global Forecast to 2028

The global sweeteners market is projected to reach USD 125.1 billion by 2028 from 107.2 billion in 2023 at a CAGR of 3.1%. Consumers are increasingly seeking alternatives to traditional sugars, given their association with obesity, diabetes, and other health concerns. Additionally, the rise in lifestyle-related diseases has prompted a shift towards healthier dietary choices, fostering the demand for low-calorie and sugar-free sweeteners. Moreover, the increasing prevalence of conditions like diabetes has led to a surge in demand for sugar substitutes among health-conscious individuals. Food and beverage manufacturers are responding to this trend by incorporating various sweeteners into their products to cater to diverse consumer preferences. Technological advancements in sweetener production, including innovations in natural sweeteners like stevia and monk fruit, further contribute to market growth. As the health and wellness trend continues to gain traction globally, the sweeteners market is poised to expand, offering a broad spectrum of choices to meet evolving consumer needs.

Sweeteners Market

Sweeteners Market Trends

The sweeteners market has been experiencing several notable trends in recent years:

1. Growing Demand for Natural Sweeteners: Consumers are increasingly seeking natural alternatives to traditional sugar due to concerns about health and wellness. Natural sweeteners like stevia, monk fruit, and erythritol have gained popularity as they offer sweetness without the calories or negative health effects associated with refined sugar.

2. Rise of Low-Calorie and Sugar-Free Products: With increasing awareness of the health risks associated with excessive sugar consumption, there’s been a surge in demand for low-calorie and sugar-free products. This trend has propelled the growth of artificial sweeteners such as aspartame, sucralose, and saccharin, which are used in a variety of food and beverage applications.

3. Clean Label Movement: Consumers are paying more attention to ingredient lists and seeking products with natural, recognizable ingredients. As a result, there’s a growing demand for sweeteners that are perceived as “clean” or minimally processed, driving the popularity of options like coconut sugar, agave nectar, and honey.

4. Expansion of Functional Sweeteners: Functional sweeteners are those that offer additional health benefits beyond sweetness. Examples include prebiotic sweeteners like inulin and oligosaccharides, which promote gut health, and sugar alcohols like xylitol and sorbitol, which have dental health benefits. As interest in functional foods grows, so does the demand for sweeteners that offer added health perks.

5. Innovation in Sweetener Blends: To achieve the desired taste profile while reducing sugar content, manufacturers are increasingly turning to blends of different sweeteners. These blends can offer a more balanced sweetness with fewer calories and reduced impact on blood sugar levels. Additionally, combining natural and artificial sweeteners can help mask any off-flavors or aftertastes associated with certain sweeteners.

6. Regulatory Changes and Labeling Requirements: Regulatory bodies are continuously evaluating the safety and labeling of sweeteners, which can impact product formulation and marketing strategies. For example, there have been debates and changes in regulations regarding the labeling of added sugars and the use of certain artificial sweeteners in food and beverage products.

Sweeteners Market Opportunities: Research and development for diabetic-friendly sweeteners

The escalating global burden of diabetes, according to the International Diabetic Federation Atlas (2021), reporting 10.5% of adults (20–79 years) living with the condition and projecting a 46% increase to 783 million individuals by 2045, underscores a significant opportunity for the sweeteners market. Over 90% of those affected have type 2 diabetes, driven by urbanization, an aging population, declining physical activity, and rising overweight and obesity rates.

The prevalence of diabetes has increased substantially, leading to a growing demand for sweeteners that are safe for people with diabetes. Consumers are now more aware of the health impact of their diet, leading to research and development initiatives focused on creating sweeteners that have better taste profiles and minimal impact on blood sugar levels. The potential for these sweeteners is further amplified by regulatory support and the increasing consumer preference for healthier options. Companies that invest in and market diabetic-friendly sweeteners not only cater to a specific demographic but also contribute to product diversification, global market expansion, and potential collaborations within the food and beverage industry. In essence, the rise of diabetes presents a strategic opportunity for the sweeteners market to become a key driver of growth and differentiation.

Based on type, the high-intensity sweeteners segment is estimated to hold the largest market share during the forecast period of the sweeteners market.

High-intensity sweeteners claim the largest share in the sweeteners market due to their exceptional sweetness potency, offering a sweet taste without the associated caloric content. As consumers increasingly prioritize healthier lifestyles and seek alternatives to traditional sugars, high-intensity sweeteners, such as aspartame, sucralose, and steviol glycosides (from stevia), have gained widespread popularity. The ability of these sweeteners to provide sweetness at levels significantly higher than sucrose enables their usage in minimal quantities, appealing to those aiming to reduce calorie intake.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186278129

North America is Projected To Be The Fastest-Growing Region in the Sweeteners Market.

North America is growing at a significant rate in the sweeteners market due to a confluence of factors driving demand and consumption patterns. The region’s high prevalence of health-conscious consumers and their increasing awareness of the adverse effects of traditional sugars on health contribute significantly to the demand for sweeteners. With a robust food and beverage industry, North America is quick to adopt innovations in low-calorie and sugar-free alternatives, propelling the growth of the sweeteners market.

Moreover, stringent regulatory measures promoting healthier dietary choices and clearer labeling practices align with consumer preferences, further supporting the growth of the sweeteners market in North America. Canada, as part of North America, has implemented a thorough safety assessment process before approving new food additives, including sugar substitutes. This meticulous approach guarantees that only proven and safe sweeteners, such as acesulfame-potassium, polydextrose, sucralose, thaumatin, and various sugar alcohols, are permitted for use.

Top Companies in the Sweeteners Market

The key players in this market include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), Ingredion Incorporated (US), Tate & Lyle (UK), Associated British Foods (UK), Südzucker AG (Germany), and Ajinomoto Co., Inc. (Japan).

Cargill, Incorporated

Cargill, Incorporated is a privately held company, involved in the production of a range of specialty food ingredients and industrial products for various applications. The company is divided into four business segments which are animal nutrition & protein, food ingredients & applications, origination & processing, and industrial & financial services. Through its food ingredients & applications segment, it offers sweeteners to food and beverage manufacturers, food service companies, and other retailers. Some of the specialty food ingredients it provides include acidulants, sugar sweeteners, starches, and protein ingredients. These ingredients are used in the bakery, beverage, dairy, and meat sectors to improve the appearance, taste, and stability of fresh meat, specialty meat products, and beverages.

Cargill, Incorporated operates in approximately 70 countries with an additional sales presence in nearly 125 countries across North America, Latin America, Asia Pacific, Europe, the Middle East, and Africa. Some of its subsidiaries include Cargill Meat Solutions (US), Cargill Enterprises Inc. (Russia), Cargill Asia Pacific Holdings Pte Limited (Singapore), Cargill RSA (Pty) Limited (South Africa), Cargill España SA (Spain), Cargill Nordic A/S (Sweden), Provimi (Netherlands), and NatureWorks (US).

In March 2021, Cargill, Incorporated (US) and DSM (Netherlands) underwent a joint venture called Avansya for commercial-scale production of EverSweet stevia sugar substitutes. This assisted in catering to the growing demand for reduced-calorie food and beverages.

ADM

ADM is a prominent global leader in the agricultural industry. Founded in Chicago, Illinois, ADM has a rich history spanning several years. The company is involved in the production, processing, transportation, and merchandising of agricultural commodities, products, and ingredients. ADM offers a diverse range of products that include food and beverage ingredients, animal feed, biofuels, natural flavors and colors, vegetable oil, corn sugar substitutes, flour, and health and nutrition products.

ADM’s Nutrition segment is particularly significant in the sweeteners market. The segment produces a range of food and beverage ingredients, including essential components such as sweeteners, glucose, and starch, which enhance the flavor, texture, and nutritional content of various food and beverage products.

ADM has manufacturing and processing facilities all over the world, through which it competes with other leading agricultural processors like Ingredion Incorporated (US) and Doehler Group (Germany). The company works closely with its customers, using extensive research to develop innovative solutions that accelerate growth and increase business efficiencies. ADM has a vast network spanning over 200 countries and operates through subsidiaries such as Golden Peanut Company LLC (US), ADM Milling (US), ADM do Brazil Ltd. (Brazil), and ADM Hamburg AG (Germany).

In March 203, ADM (US) announced the signing of a joint venture agreement with Marel (Netherlands), a prominent provider of advanced food processing solutions. This joint venture facilitated the establishment of an innovation center at the esteemed Wageningen Campus in the Netherlands, which is known as the heart of the country’s food valley, and its opening is subject to regulatory approvals and is expected to take place in the latter half of 2024. It is specifically designed to facilitate the partnership between food manufacturers, food scientists, extrusion experts, and culinary professionals.

Key Questions Addressed by the Sweeteners Market Report:

What is the current size of the sweeteners market?

Which are the key players in the market?

Which region is projected to grow at a highest rate in the sweeteners market?

Which product is projected to grow at the highest rate during the forecast period?

Which application is projected to account for the fastest growth of the sweeteners market?

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/sweeteners-market-186278129.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Sweeteners Market Size, Share, Industry Overview, Trends, Growth Drivers, Business Opportunities, and Leading Players

Agricultural Biologicals Market Size, Share, Industry Overview, Trends, Growth Drivers, Business Opportunities, and Leading Players

“MarketsandMarkets™”

Agricultural Biologicals Market by Function, Product Type (Microbials, Macrobials, Semiochemicals, Natural products), Mode of Application (Foliar Spray, Soil & Seed treatment), Crop Type (Cereals & Grains, Fruits) & Region – Global Forecast to 2028

According to MarketsandMarkets, the global Agricultural biologicals market is projected to reach USD 27.9 billion by 2028 from USD 14.6 billion by 2023, at a CAGR of 13.8%. The global expansion of the organic farming sector is playing a pivotal role in driving the growth of the agricultural biologicals market. Organic farming practices, which necessitate the utilization of natural inputs and biologicals, are a significant catalyst for this growth. Organic farmers prioritize sustainable and environmentally friendly approaches, leading to a surge in demand for agricultural biologicals. This increased demand stems from the industry’s commitment to eco-friendly solutions and contributes to the market’s upward trajectory.

Agricultural Biologicals Market

Agricultural Biologicals Market Trends

The agricultural biologicals market has been witnessing significant growth driven by several key trends:

1. Increasing Demand for Organic Products: With a growing awareness about health and environmental concerns, there’s a rising demand for organic food products. Agricultural biologicals, such as biopesticides, biofertilizers, and biostimulants, are seen as sustainable alternatives to conventional chemical inputs, supporting organic farming practices.

2. Regulatory Support: Governments worldwide are implementing regulations favoring the use of biologicals over synthetic chemicals to reduce environmental pollution and promote sustainable agricultural practices. Regulatory support in the form of subsidies, grants, and incentives is encouraging farmers to adopt agricultural biologicals.

3. Advancements in Biotechnology: Advances in biotechnology, including genetic engineering and microbial technology, are driving innovation in the development of new and improved agricultural biological products. This has led to the discovery of novel strains of beneficial microorganisms and the development of more effective biopesticides and biostimulants.

4. Focus on Sustainable Agriculture: Sustainable agriculture practices are gaining traction globally due to concerns about soil degradation, water pollution, and climate change. Agricultural biologicals play a vital role in sustainable agriculture by improving soil health, enhancing nutrient uptake, and reducing the reliance on synthetic chemicals.

5. Increasing Investments and Partnerships: The agricultural biologicals market is attracting significant investments from both established agrochemical companies and startups specializing in biotechnology. These investments are fueling research and development activities aimed at expanding product portfolios and improving the efficacy of agricultural biologicals. Additionally, partnerships between biotech firms, agricultural companies, and research institutions are facilitating technology transfer and commercialization efforts.

6. Growing Adoption in Developing Countries: Developing countries are increasingly adopting agricultural biologicals as they seek to improve crop yields, reduce chemical residues, and enhance food security. Market players are targeting these regions with tailored solutions and affordable products to address the specific needs and challenges faced by smallholder farmers.

7. Consumer Awareness and Demand: Consumers are becoming more conscious of the environmental and health impacts of conventional farming practices, leading to a preference for products grown using sustainable and environmentally friendly methods. This shift in consumer preferences is driving demand for crops produced with the help of agricultural biologicals.

Agricultural Biologicals Market Opportunities: The Rise of Integrated Pest Management: Driving Opportunities for Agricultural Biologicals

Integrated Pest Management (IPM) is gaining global recognition as a holistic approach that combines diverse pest control strategies, including biological control methods. Within the realm of IPM, agricultural biologicals play a crucial role in promoting sustainable pest management practices and reducing reliance on chemical pesticides. As the adoption of IPM practices continues to increase worldwide, it presents significant opportunities for the utilization of agricultural biologicals across diverse cropping systems. By integrating biological control agents, such as beneficial insects, microbial-based products, and plant extracts, into IPM strategies, farmers can effectively manage pests while minimizing negative impacts on the environment and human health.

This growing acceptance of IPM as an effective and sustainable approach to pest management creates a favorable market environment for agricultural biologicals. The adoption of IPM practices encourages the exploration and utilization of biological alternatives to chemical pesticides, as they align with the goals of minimizing chemical inputs and promoting ecological balance. As a result, agricultural biologicals are being increasingly recognized as integral components of IPM programs, providing opportunities for manufacturers to develop and introduce innovative biological products that cater to the specific needs of diverse cropping systems. With IPM gaining momentum globally, the agricultural biologicals market stands poised to thrive as it continues to contribute to sustainable and environmentally friendly pest management practices.

North America is expected to dominate the market during the forecast period.

The agricultural biologicals market has seen significant growth in North America, primarily due to the high level of awareness and willingness among farmers in the United States and Canada to adopt sustainable agricultural practices. Farmers in these regions have recognized the increasing demand for organic and sustainable food, as well as the concerns surrounding chemical pesticide use. Consequently, they have actively sought alternatives such as agricultural biologicals, which has fueled market growth.

North America also benefits from well-established distribution networks and marketing channels for agricultural inputs. The presence of established agricultural input suppliers, including distributors and retailers, has played a crucial role in making agricultural biologicals easily accessible and readily available to farmers. This streamlined distribution system has further facilitated the growth of the agricultural biologicals market in the region.

The headquarters of key players such as Corteva Agriscience (US), Pro Farm Group Inc. (US), Valent BioSciences LLC (US) makes it a significant region in the agricultural biologicals market.

Top Companies in the Agricultural Biologicals Market

The key players in this include BASF SE (Germany), Syngenta AG (Switzerland), Bayer AG (Germany), UPL (India) and Corteva Agriscience (US). These players in this market are focusing on increasing their presence through agreements, partnerships, acquisitions, and collaborations. These companies have a strong presence in North America, Asia Pacific, and Europe. They also have manufacturing facilities along with strong distribution networks across these regions.

BASF SE (GERMANY)

BASF SE, a prominent player in the chemical producers’ industry, operates across various divisions and segments. The company’s 11 divisions are categorized into six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. BASF’s Agricultural Solutions unit, a part of the Nutrition & Care segment, plays a significant role in providing biological products. This includes a range of organic and conventional crop protection solutions under BASF BioSolutions, such as Bio Fungicides, Bio Insecticides, and Bio Seed Treatment. These products utilize natural defenses like beneficial nematodes, microorganisms, plant extracts, and pheromones. With a strong global presence, BASF operates in more than 90 countries, and its operations span across multiple production sites. The company has six Verbund sites, which are integrated production sites, along with 241 additional production facilities.

Syngenta AG (Switzerland)

Syngenta AG, a wholly owned subsidiary of Chic Nutaunal Arochemical Corporation (CNAC) Saturn (NL) BV, is a global market leader in crop protection products. The company operates under two primary segments: Crop Protection and Seeds. Within the Crop Protection segment, Syngenta offers a range of agricultural biologicals, including selective and non-selective herbicides, fungicides, insecticides, seed care products, and other crop protection solutions. The Seeds segment focuses on field crops, vegetables, and flowers.

With operations in over 100 countries, Syngenta has a strong global presence and aims to revolutionize crop cultivation and protection practices. The company’s Crop Protection segment experienced notable sales improvement, driven by the recovery and growth in the Brazilian market, as well as the introduction of new products in Europe, the Middle East, Africa (EMEA), and the United States.

Bayer AG (Germany)

Bayer, a leading life science company, operates across three business segments: pharmaceuticals, crop science, and consumer health. Within its Crop Science segment, Bayer is a prominent player in the agriculture industry, specializing in crop protection, seeds, and digital farming. To promote sustainable agriculture, Bayer offers a wide range of high-value seeds, advanced plant traits, innovative chemical and biological crop protection products, digital solutions, and comprehensive customer service. The company possesses a vast collection of over 125,000 microbial strains, enabling it to leverage genetic diversity for the development of new and beneficial products. Bayer is dedicated to delivering solutions through cutting-edge research in microbial and RNAi (RNA interference) technology, which enhances the efficiency of its products. The acquisition of Monsanto has further accelerated Bayer’s research in RNAi technology, leading to advancements in crop protection solutions.

Bayer conducts studies to explore how microorganisms can contribute to increased crop productivity and plant health. Its experts invest significant time in determining the most effective microbial strains for specific environments to support optimal plant growth. Each year, Bayer’s researchers conduct in vitro screenings of more than 10,000 microorganisms, evaluating their potential benefits in agriculture.

Agricultural Biologicals Industry News

In July 2023, A distribution agreement for the product Essen’ciel for the Italian and Spanish markets was signed by BASF and Vivagro, a cutting-edge French firm specializing in agroecological solutions. Based on sweet orange essential oil, Essen’ciel is a natural fungicide, pesticide, and acaricide. Vine grapes, vegetable crops, berries, ornamental crops, industrial crops, and arboriculture are among the organic uses that have been allowed for it. Given the lack of insecticide alternatives, Essen’ciel stands as an alternative biocontrol agent, particularly for pip fruits like apples, pears, and quinces.

In January 2022, In a strategic move, Syngenta Crop Protection AG has completed the acquisition of Bionema Limited’s advanced bioinsecticides, namely NemaTrident and UniSpore. These cutting-edge biocontrol solutions offer customers additional and complementary technologies to efficiently and sustainably combat insect pests and address issues of resistance. With this acquisition, NemaTrident and UniSpore become the first fully owned biocontrol products in Syngenta Professional Solutions’ portfolio.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=100393324

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Agricultural Biologicals Market Size, Share, Industry Overview, Trends, Growth Drivers, Business Opportunities, and Leading Players

Future of Batteries Market worth 62 million units by 2035, at a CAGR of 12.7%

“Future of Batteries Market”

Future of Batteries Market by Type (Li-ion, Na-ion, Solid state, Li- Air), Vehicle Type (Passenger Cars, Commercial Vehicles, Off-Road Vehicles), Battery Form (Prismatic, Pouch, Cylindrical), Packaging (CTM, CTP, CTC, MTC) & Region – Global Forecast 2035

The global future of batteries market is projected to grow from 16 million units in 2024 to 62 million units by 2035, at a CAGR of 12.7%.

Higher standard batteries have been introduced due to recent developments in the EV market. Even though new batteries should increase EV performance and range, consumers are still hesitant to pick EVs over internal combustion engine (ICE) vehicles due to a number of issues, including EVs’ short range, lengthy charging times, high cost, and scarcity of charging stations. Consequently, EV battery manufacturers are focusing on creating new batteries with innovative, quick, and rapid charging technologies to overcome these challenges. In addition, advances in manufacturing processes such as automation and creative assembly methods are being made to lower expenses and improve battery production’s scalability. This includes advancements in pack integration, cell assembly, and electrode fabrication. These developments are anticipated to have a lucrative impact on market expansion.

Cylindrical segment is expected to grow at the fastest rate during the forecast period

The cylindrical segment is projected to register the highest CAGR during the forecast period. Durable and long-lasting are two characteristics of cylindrical batteries. Due to their excellent confinement and effective mechanical resistance against internal and external pressures, cylindrical cells are the least expensive to manufacture compared to alternative EV battery types. Manufacturers are starting to use cylindrical batteries as well. Tesla, for instance, uses cylindrical batteries due to their dependability and robustness. The new generation of cylindrical batteries, like the 4680 format pioneered by Tesla, boasts significant improvements in range and efficiency compared to older models.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243513539

Solid state battery expected to be the next big shift during forecast period

Emerging solid-state battery technology has various potential benefits for electric vehicles. Unlike traditional lithium-ion batteries, which utilize liquid electrolytes, they use solid electrolytes. Because solid electrolytes are less likely to experience problems like leaking, overheating, and fire hazards, they are considered safer overall for electric vehicles. Faster charging times could be possible using solid-state batteries as opposed to lithium-ion batteries. Because of their enhanced conductivity and capacity to tolerate higher charging rates, EVs may require fewer charging cycles, saving users time and increasing convenience. For instance, In October 2023, Toyota secured a deal to mass-produce solid-state EV batteries with a 932-mile range. Using materials developed by Idemitsu Kosan will allow Toyota to commercialize these energy-dense batteries by 2028. Solid-state batteries can significantly extend a vehicle’s driving range as well. It is projected that a solid-state battery replacement may quadruple the driving range of the Tesla Roadster. Such benefits will help the solid-state battery market grow over the projected period.

North America to be the prominent growing market for EV batteries during the forecast period

The automotive sector in North America is one of the most developed worldwide. Major commercial automakers like Tesla, Proterra, MAN, and NFI Group are based in the region, which makes it well-known for its cutting-edge EV R&D, inventions, and technological advancements. These businesses are investing in constructing and expanding battery production plants in North America. To meet the growing demand for electric vehicles, these facilities produce sophisticated battery technology, including lithium-ion batteries. The US has historically led the way in technology in North America. Leading EV battery suppliers and startups have partnered with OEMs in the North American EV market. For example, GM and LG Chem have partnered.

On the other hand, Stellantis and Samsung SDI are working together to develop EV batteries. Additionally, Ford and SK Innovation are working together. Tesla produces its own EV battery products. These companies are working together to set up production facilities in the United States. Additionally, a number of state and federal laws and programs are promoting the use of EVs and the growth of the EV battery industry. This covers tax breaks for buying electric vehicles, capital expenditures for infrastructure related to charging, and battery research and development financing. In addition, OEMs are focusing more on introducing electric buses, vans, and trucks; this will likely result in a significant growth in the North American EV battery business. Another factor expected to propel expansion in the North American EV battery is the growing need for fleets of zero-emission freight and public transit vehicles.

Key Players

The major players in Future of Batteries market include CATL (China), BYD Company Ltd. (China), LG Energy Solution Ltd. (South Korea), Panasonic Holdings Corporation (Japan), and SK Innovation Co., Ltd. (South Korea). These companies adopted various strategies, such as new product developments and deals, to gain traction in the market.

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=243513539

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Future of Batteries Market worth 62 million units by 2035, at a CAGR of 12.7%

Global Texture Paint Market Growth Analysis, Size, Opportunities, Key Producers, Share, Trends, Segmentation, Regional Graph, and Forecast to 2028

“Browse 268 market data Tables and 64 Figures spread through 355 Pages and in-depth TOC on “Texture Paint Market””

Texture Paint Market by Resin Type (Acrylic and Epoxy), Technology (Water based, Solvent based), Product Type (Interior and Exterior), Application (Residential and Non – Residential), & Region (Asia Pacific, Europe, North America – Global Forecast to 2028

The global texture paint market size is projected to grow from USD 12.5 billion in 2022 to USD 16.2 billion by 2028, at a CAGR of 4.4%. The demand for texture paint is primarily influenced by the demand trends in the residential and non-residential sector in the growing economy. The companies have adopted various strategies, such as mergers & acquisitions, investment & expansion, joint ventures, & new product launches and to increase their global presence and maintain sustained growth in the texture paint market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215881072

The Asia Pacific region has seen a rise in the middle-class population and increasing disposable incomes. As people’s living standards improve, there is a growing demand for better housing, interior design, and home renovation. Texture paint offers a cost-effective way to upgrade living spaces and achieve visually appealing surfaces, making it a popular choice among consumers in the region.

The major players in the global texture paint market are PPG Industries (US), AkzoNobel N.V. (Netherlands), The Sherwin-Williams Company (US), Asian paints limited (India) and Jotun A/S (Norway). These players opted for inorganic growth through mergers & acquisitions, agreements, and partnerships. For instance, in April 2023, AkzoNobel N.V. is to further strengthen its China position after reaching an agreement with Sherwin-Williams to acquire its Chinese Decorative Paints business. Completion, which is subject to regulatory approvals, is expected in the second half of 2023.

There are various small, medium, and large players operating in the market. Some of the major market players include The Sherwin-Williams Company (US), PPG Industries, Inc (US), AkzoNobel N.V. (The Netherlands), Asian paints limited (India), Jotun A/s (Norway), Kansai Paint Co., Ltd (Japan), Nippon Paint Holding Co., Ltd (Japan). To grow its market share, they have used different development approaches such as investment and expansion, mergers and acquisitions, and joint ventures.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=215881072

PPG Industries, Inc: PPG Industries is a global leader in paints, coatings, and specialty materials. The company operates in various segments and offers a wide range of products and services to customers worldwide. PPG Industries serves customers in various industries, including automotive, construction, aerospace, industrial, and consumer products. The company focuses on innovation, sustainability, and customer collaboration to develop advanced coatings and materials that meet evolving market demands. PPG is known for its global presence, strong brand recognition, and commitment to delivering quality products and services. As a leading player in the coatings and specialty materials industry, PPG Industries continues to invest in research and development, strategic partnerships, and global expansion to maintain its competitive position and drive growth in key markets.

PPG acquired Tikkurila in June 2021, which is expected to assist the firm extend its paints and coatings choices, which will now include Tikkurila’s texture paints.

Akzo Nobel N.V: AkzoNobel is a global leader in paints, coatings, and specialty chemicals. The company operates in various business segments and offers a wide range of products and services to customers across the world. AkzoNobel is known for its strong brand portfolio, innovative products, and commitment to sustainability. The company places a strong emphasis on research and development to develop environmentally friendly and technologically advanced coatings and chemicals. AkzoNobel’s products aim to provide solutions that meet customer needs while minimizing environmental impact.

In June 2022, AkzoNobel acquired kansai paints and coating business in Africa which help the company to provide a strong platform for future growth.

Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=215881072

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Global Texture Paint Market Growth Analysis, Size, Opportunities, Key Producers, Share, Trends, Segmentation, Regional Graph, and Forecast to 2028

Silicone Market Size, Opportunities, Share, Key Development, Top Suppliers, Growth, Regional Trends, Key Segments, Graph and Forecast to 2027

“Browse 355 market data Tables and 40 Figures spread through 273 Pages and in-depth TOC on “Silicone Market””

Silicone Market by Type (Elastomers, Fluids, Resins, Gels), End-use Industry (Industrial Process, Building & Construction, Personal Care & Consumer Products, Transportation, Electronics, Medical & Healthcare, Energy), and Region – Global Forecast to 2027

The silicone market is projected to grow from USD 18.5 billion in 2022 to USD 27.0 billion by 2027, at a CAGR of 7.8% during the forecast period. Superior properties of silicone and high demand for silicone in electronics industry will drive the silicone market during the forecast period. Unique properties of silicone such as durability, dielectricity, adhesion, foam control, discharge safety, UV stability, glossiness, transparency, radiation resistance, hydrophobicity, heat resistance, and flexibility make it one of the most versatile products used in a wide range of industries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=709

Most manufacturers in this market are based in North America, Europe and Asia Pacific. Wacker Chemie AG (Germany), Shin-Etsu Chemical Co., Ltd. (Japan), Elkem ASA (Norway), The Dow Chemical Company (US), Momentive Performance Materials, Inc. (US), Gelest, Inc. (US) are among the leading players operating in the silicone market. These players have adopted various growth strategies to strengthen their position in the market. This include product launches, expansions and acquisitions, and new product development activities further to expand their presence in the silicone market.

Wacker Chemie AG

Wacker Chemie AG (Germany) is one of the leading silicone manufacturers across the globe. The product portfolio of the company includes silicone fluids, emulsions, elastomers, sealants, and resins to pyrogenic silicas. The company serves different end markets, such as construction, automobile, paints, textiles, cosmetics, electronics, and paper. The company has presence in Europe, North America, South America and Asia Pacific.

Shin-Etsu Chemical Co., Ltd.

Shin-Etsu Chemical Co., Ltd. (Japan) is the largest manufacturer of silicones in Japan. The company offers over 5,000 silicone based products for users in a wide range of industries, such as electrical/electronic manufacturing, auto manufacturing, construction, cosmetics, healthcare, and chemical. The company has production facilities and sales offices globally, including Japan, the US, South Korea, China, Taiwan, Singapore, Thailand, and the Netherlands.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=709

Elkem ASA

Elkem ASA (Norway) is known for its environmentally friendly silicone. The company serves various industries, such as agriculture, construction, electrical & electronics, energy, food & beverage, home & personal care, life science, pulp & paper, rubber, plastic & composite, textiles & leather, and transportation. The company provides silicone products through its Elkem Silicones division under the brand BLUESIL, CAF, LSR SELECT, MIX ANA FIX CENTER, SILBIONE, SILCOLEASE, SILCOLAPSE, LYNDCOAT, and MIRASIL. The company has production facilities in Europe, North America, South America, Africa, and Asia.

The Dow Chemical Company

The Dow Chemical Company (US) is one of the leading chemicals and plastics manufacturers serving various industries such as packaging, infrastructure, transportation, consumer care, electronics, and agriculture. The company offers silicone products under the brand name XIAMETER and DOWSIL. The company has its presence in Europe, Middle East & Africa, Asia Pacific, North America and South America.

Momentive Performance Materials, Inc.

Momentive Performance Materials, Inc. (US) is one of the largest producers of silicone and its derivatives. The company also offers silicone surfactants and serves industries, such as automotive, electronics, personal care, consumer products, aerospace, and building and construction. The company has presence in the US, Canada, Colombia, Brazil, Germany, the Netherlands, Italy, Belgium, the UK, China, Japan, Singapore, Thailand, India, Australia, France, Mexico, New Zealand, and Turkey.

Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=709

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Silicone Market Size, Opportunities, Share, Key Development, Top Suppliers, Growth, Regional Trends, Key Segments, Graph and Forecast to 2027

BioMatrix Revealed as the Surprising Contender at TOKEN2049: Launches Beta App to Redefine Inclusive Finance via Universal Basic Income

California – April 30, 2024 – In the wake of the prestigious global fintech summit TOKEN2049 in Dubai, the innovative tech company BioMatrix leveraged this prime moment to host the side event “Web3 for Everyone.” The launch gathered tech aficionados, leading project heads, journalists, and investors from across the world, who together witnessed to the release of BioMatrix’s mobile app Beta version. The company encouraged early-stage public participation and feedback to cohesively refine and advance the product. This BioMatrix app is the principal portal into its revolutionary ecosystems, “BioPass” and “Proof of You (PoY) token,” epitomizing the company’s mission to craft a more inclusive and sustainable future worldwide, where digital financial benefits are accessible to all.

BioMatrix’s ecosystem is at the forefront of innovation, combining blockchain with artificial intelligence to shape the future of digital transactions. These advanced platforms pave the way for a fair, open, and streamlined digital economy. This app’s launch marks more than a new product; it embodies BioMatrix’s commitment to fostering social good and creating a more connected, accessible digital world.

BioMatrix envisions a world where technological advancements do more than drive commercial success. The company weaves compassion and social responsibility into every stage of innovation, aiming to create a fairer and more equitable society. Committed to societal welfare, BioMatrix consistently seeks out ways for technology to serve people better, irrespective of their socioeconomic status.

The event in Dubai marked a significant step for BioMatrix onto the global scene. The company showcased its strength and vision in tech innovation, encouraging a wider group of partners and users to embrace the web 3.0 digital revolution. As an innovator, BioMatrix welcomes partnerships to build a prosperous, inclusive, and sustainable digital world. At the launch, BioMatrix CEO Alex stressed that the core of innovation is to simplify life and protect personal value, a principle at the heart of BioMatrix’s approach to product development.

The beta version of BioMatrix’s leading product is now up for downloads on Google Play and the App Store. This launch is more than just a product debut; it’s a venture into the future of digital living. BioMatrix is committed to integrating technology with human-centric values, constantly bringing fresh, innovative experiences to people around the globe. Following this successful event, they look forward to seeing BioMatrix chart new courses in the digital age, leading to exciting changes and advancements.

For Further Information, Please Check:

Google Play: https://bit.ly/web3foreveryone

Apple Store: https://apps.apple.com/us/app/biomatrix/id6482980838?l=zh-Hans-CN

Website: https://biomatrix.ai/

Telegram: @BioMatrix.ai

Keep an eye out for BioMatrix’s upcoming innovative brand and technological solutions post-TOKEN 2049. For additional information or to arrange an interview, feel free to reach out to us anytime.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: A&C Technology
Contact Person: Yue Luo
Email: Send Email
Country: United States
Website: https://biomatrix.ai/

Bottled Water Processing Market Size, Share, Industry Overview, Trends, Growth Drivers, Business Opportunities, and Leading Players

“MarketsandMarkets™”

Bottled Water Processing Market by Product Type (Still Water and Sparkling Water), Packaging Material, Technology (Ion Exchange & Demineralization, Disinfection, Filtration, and Packaging), Equipment and Region – Global Forecast to 2028

The global bottled water processing market comprises the bottled water market and the bottled water equipment market. The bottled water equipment market is estimated at USD 7.2 billion in 2023 and is projected to reach USD 9.5 billion by 2028, at a CAGR of 5.7% from 2023 to 2028. Whereas the bottled water market is estimated at USD 311.1 billion in 2023 and is projected to reach USD 457.1 billion by 2028, at a CAGR of 8.0% from 2023 to 2028.

Bottled Water Processing Market

The bottled water processing market in the Asia Pacific region has witnessed substantial growth, particularly in countries with limited access to publicly provided piped water sources. As highlighted by Foster et al. in 2021, reports from the World Health Organization (WHO) and UNICEF, bottled water has become a prevalent choice for self-supply in areas facing challenges in accessing clean and safe drinking water through traditional public water supply systems. Several factors contribute to the rising reliance on bottled water in these regions. First and foremost is the imperative to ensure a consistent and safe supply of drinking water. Government failures in providing quality drinking water through local utilities, coupled with the limitations of water delivery infrastructure in urban centers experiencing rapid urbanization, have created a demand for alternative solutions.

Bottled Water Processing Market Trends

The bottled water processing market has been witnessing several trends influenced by changing consumer preferences, technological advancements, regulatory requirements, and sustainability concerns. Here are some key trends:

1. Health and Wellness Focus: Consumers are increasingly seeking healthier beverage options, driving the demand for bottled water perceived as a healthier alternative to sugary drinks. This trend is especially pronounced in regions where concerns about obesity and sugar intake are high.

2. Premiumization: There’s a growing demand for premium and value-added bottled water products, such as flavored, vitamin-enhanced, or functional waters. This trend is driven by consumers willing to pay more for perceived benefits like hydration, energy, or added nutrients.

3. Sustainability: With rising environmental awareness, consumers are becoming more conscious of the environmental impact of single-use plastic bottles. As a result, there’s a shift towards eco-friendly packaging solutions, such as biodegradable bottles, recycled materials, or alternative packaging formats like cans or cartons.

4. Technological Advancements: Innovations in water treatment and purification technologies are improving efficiency, reducing costs, and enhancing the quality of bottled water. Advanced filtration systems, UV sterilization, and ozone treatment are some examples of technologies being adopted to ensure water safety and purity.

5. Convenience and Portability: Busy lifestyles and on-the-go consumption patterns are driving the demand for convenient and portable packaging formats, such as single-serve bottles, pouches, and smaller pack sizes. This trend is particularly strong among urban consumers and frequent travelers.

6. Flavor Innovation: Manufacturers are introducing a wide variety of flavors and botanical infusions to cater to diverse consumer preferences and enhance the taste profile of bottled water. Natural flavors, exotic fruits, and herbal extracts are increasingly being used to create unique and appealing beverage options.

7. Transparency and Traceability: Consumers are demanding greater transparency regarding the source and production process of bottled water. Brands are responding by providing detailed information about the origin of water, purification methods, and quality testing results to build trust and credibility with consumers.

8. Regulatory Compliance: Stringent regulations governing water quality, safety standards, and labeling requirements are shaping the bottled water processing industry. Manufacturers need to ensure compliance with local and international regulations to maintain product integrity and consumer confidence.

Bottled Water Processing Market Opportunities: Desalination Plants Drives Surge in Bottled Water Processing Equipment Industry

With increasing urbanization, there is a rise in demand for better quality drinking water, which, in turn, increases the need for membrane filtration processing in water and wastewater treatment applications globally. Rising concern regarding wastewater discharge and drinking water quality is also driving the bottled water processing market globally.

In the past decade, the desalination market has seen an unprecedented rise, as the sources of fresh water are becoming limited. However, the use of desalination units and plants is limited to deserts or areas where the sources of water are saline. Saudi Arabia, the United States, the UAE, and Kuwait have the highest desalination capacities in the world. Saudi Arabia has the world’s biggest desalination capacity, accounting for about one-fifth of the global desalination capacity. The rise in the desalination market has invariably increased the demand for water purification, which is used in the bottled water industry.

Desalination plants, utilizing advanced processes such as Reverse Osmosis (RO), provide a crucial avenue for diversifying water sources for the bottled water industry. In regions where freshwater is scarce, these facilities offer an alternative, ensuring a consistent supply of high-quality water for bottling operations. The reliability of desalinated water aligns seamlessly with the stringent quality standards demanded by consumers in the bottled water market.

The Asia Pacific region accounted for the largest share in 2022 in terms of value.

The Asia Pacific region is witnessing a surge in the adoption of innovative and sustainable bottled water processing technologies. With a growing awareness of environmental concerns related to single-use plastics, there is an increasing emphasis on developing eco-friendly packaging solutions and promoting recycling initiatives. This reflects a broader trend in the region towards environmentally responsible consumption, influencing both consumer choices and industry practices within the bottled water processing market. Government initiatives and regulations regarding water quality standards and safety further contribute to the evolution of the bottled water processing landscape in the Asia-Pacific region. As regulatory frameworks become more stringent, manufacturers are compelled to invest in advanced processing technologies to meet compliance requirements and ensure the production of high-quality, safe drinking water. Additionally, the diversity of the Asia Pacific market extends to the types of bottled water consumed, including purified water, mineral water, and functional or enhanced water products.

Top Companies in the Bottled Water Processing Market

Key players operating in bottled water equipment market include Bottled Water Equipment Market :

DuPont (US), GEA Group Aktiengesellschaft (Germany), Alfa Laval (Sweden), 3M (US), Veolia (France) SPX FLOW, Inc. (US), Pall Corporation (US), Pentair (US), Porvair Filtration Group (UK), TORAY INDUSTRIES, INC. (Japan). Key players in bottled Water Market include Nestlé (Switzerland), The Coca-Cola Company (US), PepsiCo (US), Danone (France), Nongfu Spring (China), Tata Consumer Products Limited (India), National Beverage Corp. (US), Keurig Dr Pepper Inc. (US), Gerolsteiner Brunnen GmbH & Co. KG (Germany), CG Roxane, LLC (US).

Other Players in the ecosystem:

Creative OZ Air (I) Pvt. Ltd., Marlo Incorporated, Lenntech B.V., Accuteck Packaging Equipment Companies, Inc., Evergreen technologies, Tetra Laval S.A, E-Rotek Water Systems Co., ltd., Danaher Corporation, Otsuka Pharmaceutical Co., Ltd., Primo Water Corporation, Fiji Water Company LLC, VOSS Water.

DuPont (US)

DuPont originated from the merger of Dow Chemical and DuPont, later dividing into three divisions: DuPont, Dow Chemicals, and Corteva, each specializing in agriculture, materials science, and specialty products. DuPont offers a diverse range of products across 15 lines, including adhesives, printing solutions, biomaterials, clean technologies, and more. The company operates through four segments: Electronics & Industrial, Water & Protection, Mobility & Materials, and Corporate & Other. Bottled water processing equipment falls under the Water & Protection segment, providing solutions for worker safety, water purification, transportation, energy, and medical packaging. DuPont, known for its membrane science and ion exchange technologies, addresses global challenges by ensuring safe drinking water, enhancing operational efficiency, and managing water scarcity.

With a presence in EMEA (22 locations), Asia Pacific (54 locations), US and Canada (55 locations), and Latin America (3 locations), DuPont has established itself as a global leader in purification and separation technologies.

GEA Group Aktiengesellschaft (Germany)

GEA Group Aktiengesellschaft stands as a prominent technology supplier in the food processing industry. Specializing in tailored solutions, the company serves diverse sectors, including food, dairy processing, dairy farming, beverage processing, pharmaceuticals, chemicals, marine, leisure, sport, land-based transportation, and utilities. GEA operates through five technological divisions: Separation & Flow Technologies, Liquid & Powder Technologies, Food & Healthcare Technologies, Farm Technologies, and Heating & Refrigeration Technologies.

Within the Liquid & Powder Technologies division, GEA provides processing equipment and comprehensive solutions for industries such as dairy, food (including new food varieties), beverages, chemicals, and home & personal care. The range of offerings encompasses brewing systems, liquid processing and filling, concentration, precise fermentation, crystallization, purification, drying, powder handling and packaging, along with emission control systems.

GEA specializes in providing comprehensive technologies to ensure the hygienic treatment of water, whether it’s still, carbonated, flavored, or enriched with minerals. It encompasses a full portfolio of components, modules, and process lines covering every stage of water treatment. This includes reception and handling of liquid/dry raw materials, storage solutions, processing, formulation, treatment, and complete filling lines for still, sparkling, and flavored water. Their expertise lies in delivering hygienically designed plants that meet the diverse needs of the water treatment industry.

The company has a strong presence in more than 50 countries across North America, South America, Europe, Africa, and Asia Pacific. The group operates through its subsidiaries, such as GEA Procomac S.p.A (Italy), GEA Process Engineering Private Limited (India), GEA Food Solutions (Brazil), GEA Food Solutions North America, Inc. (US), and GEA Food Solutions UK & Ireland Limited (UK). The major competitors of GEA Group Aktiengesellschaft include Pall Corporation (US), Koch Membrane Systems Inc. (US), and Alfa Laval (Sweden).

The Coca-Cola Company (US)

The Coca-Cola Company is a multinational beverage corporation headquartered in Atlanta, Georgia, US. The company has its products available in more than 200 countries and territories. It has a wide range of products in its portfolio like sparkling drinks, hydration drinks, juices, coffee and tea, and many more. The hydration products account for a good share of the retail value.

In the hydration category, the Coca-Cola company offers many products under mineral water, flavored still water, flavored and unflavored sparkling water. Under the Hydration segment, the company manufactures an extensive array of products like dasani, powerade, bodyarmor, topo chico, and many more.

Key Questions Addressed by the Bottled Water Processing Market Report:

Which region is projected to account for the largest share of the bottled water equipment market?

What is the current size of the global bottled water market?

Which are the major key players in the bottled water equipment market?

What are the factors driving the bottled water processing market?

Which segment by product type accounted for the largest bottled water market share?

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bottled Water Processing Market Size, Share, Industry Overview, Trends, Growth Drivers, Business Opportunities, and Leading Players

Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology firm at the forefront of developing and marketing rapid, intelligent, cutting-edge, and non-intrusive drug testing and health screening solutions. The company is actively involved in commercializing its smart fingerprinting device for drug testing, which has gained rapid traction in the healthcare market segment.

Drug testing traditionally involves analysing urine or saliva samples, a process that is often expensive, time-consuming, and poses biohazard risks. The demand for swift, reliable, user-friendly, and cost-effective drug testing methods, particularly in workplaces, is on the rise. Market projections indicate a substantial growth from $5.3 billion in 2023 to an estimated $28.3 billion by 2032, with urine and saliva tests leading the market. Intelligent Bio Solutions is poised to capture a significant market share with its fingerprint testing solution.

In the competitive landscape, companies like Labcorp (NYSE: LH), Quest Diagnostics (NYSE: DGX), Thermo Fisher Scientific (NYSE: TMO), Abbott Laboratories (NYSE: ABT), and OraSure (Nasdaq: OSUR) offer various drug testing services, including urine and saliva tests with different turnaround times and methodologies.

Intelligent Bio Solutions’ Fingerprinting technology has redirected the company’s focus towards a market-ready product. Their drug screening system utilizes advanced technology for detecting drugs in fingerprint sweat, delivering rapid results within minutes. This system is tailored for organizations with regular drug screening needs, promising a paradigm shift in the healthcare sector.

Moreover, Intelligent Bio Solutions Inc. (NASDAQ: INBS) is experiencing substantial global growth and is on the path to profitability. Analysts argue that the company’s shares are currently undervalued, with Ladenburg Thalmann recently issuing a buy rating for Intelligent Bio Solutions Inc. stock, setting a target price of $12 per share. For more insights, read the full TalkMarkets article.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX